Novanta Résultats passés
Passé contrôle des critères 1/6
Novanta a connu une croissance annuelle moyenne de ses bénéfices de 4.6%, tandis que le secteur Electronic a vu ses bénéfices augmenter de en hausse à 4.2% par an. Les revenus ont augmenté de en hausse à un taux moyen de 9.3% par an. Le rendement des capitaux propres de Novanta est 4.1% et ses marges nettes sont de 5.5%.
Informations clés
4.57%
Taux de croissance des bénéfices
4.06%
Taux de croissance du BPA
| Electronic Croissance de l'industrie | 15.34% |
| Taux de croissance des recettes | 9.31% |
| Rendement des fonds propres | 4.10% |
| Marge nette | 5.49% |
| Prochaine mise à jour des résultats | 11 May 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour de l'analyse • Apr 19
NOVT: Future Earnings Power Will Rely On Executing Stronger Margins
Narrative update on Novanta The consensus analyst price target for Novanta has been raised by $12 to $150. Analysts cite updated models after Q4 results that indicate potential for stronger sales and margin performance.Mise à jour de l'analyse • Apr 05
NOVT: Future Earnings Power Will Rely On Accelerating Sales And Margins
Analysts have trimmed their fair value estimate for Novanta from $160 to $157, reflecting a slightly higher discount rate and a modestly lower future P/E assumption, while still pointing to expectations for improving sales and margins after recent model updates. Analyst Commentary Bullish Takeaways Bullish analysts see room for the shares to move toward their updated fair value range, supported by model revisions that assume improving sales trends and margin recovery after recent results.Mise à jour de l'analyse • Mar 22
NOVT: Future Earnings Power Will Rely On Accelerating Margins
Analysts have lifted their price target on Novanta to $150 from $138, citing updated Q4 models that suggest the company may be positioned for faster sales growth and margin expansion. Analyst Commentary Bullish Takeaways Bullish analysts point to the raised price target to $150 as a sign that updated Q4 assumptions support a higher valuation range for the shares.Mise à jour de l'analyse • Mar 06
NOVT: Future Earnings Power Will Rely On Accelerating Margins
Analysts have lifted their fair value estimate for Novanta to $160 from $154, supported by updated models that reflect expectations for accelerating sales and margins following recent Q4 results and a higher Street price target of $150 from $138. Analyst Commentary Recent commentary points to a more constructive view on Novanta following its Q4 results, with updated models feeding into a higher fair value framework and a Street price target of $150.Mise à jour de l'analyse • Feb 20
NOVT: Stable Outlook Will Rely On Steady Margins And Earnings Multiple
Narrative Update: Novanta Analyst Price Target The analyst price target for Novanta is unchanged at $154, as analysts keep their assumptions for fair value, discount rate, revenue growth, profit margin and future P/E essentially steady. Valuation Changes Fair Value: $154.00 remains effectively unchanged compared with the prior estimate of $154.Mise à jour de l'analyse • Feb 06
NOVT: Equity Units Offering Will Support Balance Sheet And Future Deals
Analysts have nudged their price target on Novanta slightly higher to reflect modest tweaks to the discount rate, revenue growth, profit margin, and future P/E assumptions, framing the move as fine tuning rather than a major reset in expectations. What's in the News Novanta plans to look for acquisitions and investments, signaling an interest in adding to its portfolio of businesses (Key Developments).Mise à jour de l'analyse • Jan 22
NOVT: Equity Units And Share Repurchases Will Support Balance Sheet And Future Deals
Analysts now keep their price target for Novanta effectively unchanged at about $154.00. They point to steady assumptions around discount rate, revenue growth, profit margin and future P/E as the key drivers of their view.Mise à jour de l'analyse • Jan 08
NOVT: Equity Units Offering Will Strengthen Balance Sheet And Support Future Deals
Analysts have maintained their fair value estimate for Novanta at approximately $154. They cite only marginal adjustments to the discount rate, long term revenue growth, profit margin assumptions, and future P/E, which do not materially change their overall outlook.Mise à jour de l'analyse • Dec 24
NOVT: New Equity Raise Will Strengthen Balance Sheet And Support Future Deals
Analysts have maintained their price target for Novanta at approximately $154 per share. This reflects a steady outlook, as incremental adjustments to discount rate assumptions and long term growth and profitability estimates are viewed as too minor to warrant a change in fair value.Mise à jour de l'analyse • Dec 10
NOVT: Expanded Equity Offering And Buybacks Will Drive Long Term Shareholder Value
Analysts have nudged their price target for Novanta slightly higher to align with its updated fair value of $154.00, reflecting modestly stronger confidence in the company’s steady growth and margin profile. What's in the News Novanta completed a $550 million composite tangible equity units offering, issuing 11 million units priced at $50 each, with a $1.375 discount per unit (Key Developments).Mise à jour de l'analyse • Nov 26
NOVT: Expanded Buyback Authorization Will Increase Shareholder Value Going Forward
Narrative Update on Novanta: Analyst Price Target Change Analysts have maintained Novanta's fair value estimate at $154. They cited improved profitability metrics, which offset slight adjustments in the discount rate and growth projections.Mise à jour de l'analyse • Nov 10
NOVT: Equity Buyback Expansion And Profit Margin Gains Will Drive Upside
Analysts have raised their fair value estimate for Novanta from $141.50 to $154.00 per share, citing expectations for stronger future revenue growth and improved profit margins, even though the discount rate is slightly higher. What's in the News Novanta Inc.Article d'analyse • Oct 28
Novanta Inc. (NASDAQ:NOVT) Looks Just Right With A 30% Price Jump
Novanta Inc. ( NASDAQ:NOVT ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...Article d'analyse • Oct 07
Is Now The Time To Look At Buying Novanta Inc. (NASDAQ:NOVT)?
Novanta Inc. ( NASDAQ:NOVT ), is not the largest company out there, but it received a lot of attention from a...Seeking Alpha • Sep 29
Novanta: The Solution To Elevated Expectations Is Lower Prices
Summary Novanta Inc. remains a trusted technology partner for OEMs, but recent growth has been modest and organic performance underwhelming. Despite a strong track record and niche positioning, Novanta trades at a demanding 30x earnings multiple, currently posting quite flattish growth. Recent results show minimal sales and earnings growth, while NOVT leverage is set to rise due to a $200 million buyback program. I remain on the sidelines, seeking a lower entry point and a higher earnings yield to justify NOVT stock's premium and ensure a margin of safety. Read the full article on Seeking AlphaArticle d'analyse • Sep 13
Novanta's (NASDAQ:NOVT) Returns Have Hit A Wall
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...Mise à jour de l'analyse • Sep 05
Robotics And Healthcare Demand Will Expand Market Opportunities
Novanta’s fair value outlook remains unchanged, as both the discount rate and future P/E shifted only marginally, leaving the consensus analyst price target steady at $141.50. What's in the News Novanta projects third quarter 2025 GAAP revenue of $244 million to $247 million and full year 2025 GAAP revenue of $970 million to $985 million.Article d'analyse • Aug 29
Novanta Inc.'s (NASDAQ:NOVT) Share Price Matching Investor Opinion
With a price-to-earnings (or "P/E") ratio of 69.2x Novanta Inc. ( NASDAQ:NOVT ) may be sending very bearish signals at...Article d'analyse • Jun 16
Are Novanta Inc. (NASDAQ:NOVT) Investors Paying Above The Intrinsic Value?
Key Insights The projected fair value for Novanta is US$95.22 based on 2 Stage Free Cash Flow to Equity Novanta is...Article d'analyse • May 20
Returns At Novanta (NASDAQ:NOVT) Appear To Be Weighed Down
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Seeking Alpha • Apr 06
Novanta: A Trusted Yet Premium Technology Partner
Summary Novanta has shown solid growth over the past decade, but growth has been a bit sluggish in recent years. The company is a key technology partner for global OEMs, with balanced revenue from advanced industrial and medical applications, boasting strong EBITDA margins. Despite a recent acquisition and increased sales, competitive dynamics, and macroeconomic challenges have pressured growth; shares are now trading at a lower, yet still premium, multiple. With debt reduced and growth returning, shares deserve a premium, but need to fall below $100 for a more attractive valuation. Read the full article on Seeking AlphaSeeking Alpha • Jan 01
Novanta: Delayed Recovery And Prolonged Struggles Ahead, Downgrade To Sell
Summary Novanta's Q3 results show revenue growth but a decline in gross margin and shipment deferrals, indicating prolonged challenges. Macroeconomic pressures, including weak demand and high interest rates, are hindering recovery in the life sciences sector. The company's book-to-bill ratio below 1 signals weakening demand, and its high debt levels add to the risk. Novanta’s valuation is too high given its low growth prospects, especially compared to more promising peers. As a result of these factors, Novanta is downgraded from a hold to a sell, as its current price does not justify the risks. Read the full article on Seeking AlphaSeeking Alpha • Sep 02
Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold
Summary Novanta Inc. is a leading tech provider facing macroeconomic headwinds and a soft demand climate, which have pressured its revenue and profitability. Despite strong fundamentals and a solid market position, its current high valuation makes it a risky investment. NOVT has managed modest revenue growth but struggles with significant inflationary challenges. For now, a Hold rating is recommended as the stock's valuation does not align with its performance amidst ongoing market uncertainties. Read the full article on Seeking Alpha
Nouvelle analyse • Aug 28
Innovative Medical Devices And Tactical Acquisitions Poised To Accelerate Company Growth
Focusing on medical devices with new products might significantly boost future revenue through innovation, aiming for notable revenue from new launches by 2025.Ventilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment Novanta gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 25 | 981 | 54 | 196 | 95 |
| 26 Sep 25 | 960 | 53 | 188 | 98 |
| 27 Jun 25 | 957 | 61 | 181 | 97 |
| 28 Mar 25 | 952 | 71 | 179 | 96 |
| 31 Dec 24 | 949 | 64 | 177 | 96 |
| 27 Sep 24 | 923 | 60 | 175 | 94 |
| 28 Jun 24 | 900 | 62 | 170 | 92 |
| 29 Mar 24 | 893 | 69 | 168 | 92 |
| 31 Dec 23 | 882 | 73 | 165 | 92 |
| 29 Sep 23 | 888 | 76 | 161 | 90 |
| 30 Jun 23 | 890 | 77 | 162 | 89 |
| 31 Mar 23 | 876 | 73 | 160 | 88 |
| 31 Dec 22 | 861 | 74 | 159 | 86 |
| 30 Sep 22 | 841 | 73 | 156 | 83 |
| 01 Jul 22 | 796 | 64 | 147 | 79 |
| 01 Apr 22 | 748 | 58 | 137 | 75 |
| 31 Dec 21 | 707 | 50 | 130 | 73 |
| 01 Oct 21 | 655 | 49 | 122 | 69 |
| 02 Jul 21 | 621 | 44 | 117 | 67 |
| 02 Apr 21 | 598 | 44 | 111 | 64 |
| 31 Dec 20 | 591 | 45 | 110 | 61 |
| 02 Oct 20 | 603 | 41 | 112 | 60 |
| 03 Jul 20 | 614 | 42 | 113 | 58 |
| 03 Apr 20 | 624 | 40 | 118 | 57 |
| 31 Dec 19 | 626 | 41 | 119 | 56 |
| 27 Sep 19 | 623 | 43 | 117 | 54 |
| 28 Jun 19 | 629 | 56 | 119 | 54 |
| 29 Mar 19 | 625 | 57 | 119 | 53 |
| 31 Dec 18 | 614 | 51 | 116 | 51 |
| 28 Sep 18 | 605 | 39 | 115 | 50 |
| 29 Jun 18 | 591 | 18 | 113 | 48 |
| 30 Mar 18 | 559 | 12 | 108 | 44 |
| 31 Dec 17 | 521 | 40 | 102 | 42 |
| 29 Sep 17 | 473 | 48 | 94 | 38 |
| 30 Jun 17 | 425 | 55 | 86 | 34 |
| 31 Mar 17 | 403 | 54 | 82 | 33 |
| 31 Dec 16 | 385 | 22 | 81 | 32 |
| 30 Sep 16 | 376 | 20 | 80 | 31 |
| 01 Jul 16 | 371 | 19 | 80 | 31 |
| 01 Apr 16 | 369 | 34 | 81 | 31 |
| 31 Dec 15 | 374 | 36 | 82 | 31 |
| 02 Oct 15 | 377 | 1 | 85 | 32 |
| 03 Jul 15 | 380 | 0 | 86 | 32 |
Des revenus de qualité: NOVT a un important ponctuel perte de $22.7M impactant ses 12 derniers mois de résultats financiers à 31st December, 2025.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de NOVT sont inférieures à celles de l'année dernière NOVT. (5.5%) sont inférieures à celles de l'année dernière (6.8%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de NOVT ont augmenté de 4.6% par an au cours des 5 dernières années.
Accélération de la croissance: NOVT a connu une croissance négative de ses bénéfices au cours de l'année écoulée, elle ne peut donc pas être comparée à sa moyenne sur 5 ans.
Bénéfices par rapport au secteur d'activité: NOVT a enregistré une croissance négative de ses bénéfices ( -16% ) au cours de l'année écoulée, ce qui rend difficile la comparaison avec la moyenne du secteur Electronic ( 12.5% ).
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de NOVT ( 4.1% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/07 02:14 |
| Cours de l'action en fin de journée | 2026/05/07 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Novanta Inc. est couverte par 8 analystes. 3 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Robert Mason | Baird |
| Quinn Fredrickson | Baird |
| Andrew Buscaglia | Berenberg |